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Abstract
Background:  Normal post-squalene cholesterol biosynthesis is important for mammalian
embryonic development. Neonatal mice lacking functional dehydrocholesterol ∆7-reductase
(Dhcr7), a model for the human disease of Smith-Lemli-Opitz syndrome, die within 24 hours of
birth. Although they have a number of biochemical and structural abnormalities, one cause of death
is from apparent respiratory failure due to developmental pulmonary abnormalities.
Results:  In this study, we characterized further the role of cholesterol deficiency in lung
development of these mice. Significant growth retardation, beginning at E14.5~E16.5, was observed
in Dhcr7-/- embryos. Normal lobation but smaller lungs with a significant decrease in lung-to-body
weight ratio was noted in Dhcr7-/- embryos, compared to controls. Lung branching morphogenesis
was comparable between Dhcr7-/- and controls at early stages, but delayed saccular development
was visible in all Dhcr7-/- embryos from E17.5 onwards. Impaired pre-alveolar development of
varying severity, inhibited cell proliferation, delayed differentiation of type I alveolar epithelial cells
(AECs) and delayed vascular development were all evident in knockout lungs. Differentiation of
type II AECs was apparently normal as judged by surfactant protein (SP) mRNAs and SP-C
immunostaining. A significant amount of cholesterol was detectable in knockout lungs, implicating
some maternal transfer of cholesterol. No significant differences of the spatial-temporal localization
of sonic hedgehog (Shh) or its downstream targets by immunohistochemistry were detected
between knockout and wild-type lungs and Shh autoprocessing occurred normally in tissues from
Dhcr7-/- embryos.
Conclusion: Our data indicated that cholesterol deficiency caused by Dhcr7 null was associated
with a distinct lung saccular hypoplasia, characterized by failure to terminally differentiate alveolar
sacs, a delayed differentiation of type I AECs and an immature vascular network at late gestational
stages. The molecular mechanism of impaired lung development associated with sterol deficiency
by Dhcr7 loss is still unknown, but these results do not support the involvement of dysregulated
Shh-Patched-Gli pathway in causing this defect.
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Background
Cholesterol is a necessary membrane constituent of all
mammalian, reptile and avian cells, as well as a few other
organisms, but not all eukaryotic organisms. In the latter
cases, such as plants and fungi, cholesterol-like sterols
(phytosterols, ergosterol etc.) seem to substitute for cho-
lesterol. The precise need for sterols in biological mem-
branes still remains poorly defined, though its link with
microdomains (variously termed rafts, caveoli etc.) may
be part of the answer [1]. Although the accumulation of
cholesterol in atherosclerotic plaques has led to the con-
cept that 'too much' cholesterol may be deleterious, too
little cholesterol has now been proven pathophysiological
for abnormal embryonic development. Smith-Lemli-
Opitz syndrome (SLOS, MIM 270400), a relative com-
mon dysmorphology disorder, is caused by mutations in
DHCR7 [2-5], which encodes for 7-dehydrocholesterol
∆7-reductase and catalyzes a final step of cholesterol bio-
synthesis. Recognition of other dysmorphology syn-
dromes caused by defects in the post-squalene cholesterol
biosynthesis pathway, such as desmosterolosis, lathoster-
olosis, X-linked chondrodysplasia punctanta and CHILD
syndrome [6-15], has strengthened this concept.
Genetic disruption of the Dhcr7  results in neonatal
lethality [16]. Neonatal mice homozygous for the Dhcr7
gene disruption are deficient in cholesterol and have
increased accumulation of the cholesterol precursor 7-
dehydrocholesterol (7DHC). Although no embryonic
lethality was noted, these knockout pups exhibited a
number of developmental abnormalities and died within
24 h after birth. A similar mouse SLOS model, generated
by replacing exons 3, 4 and part of exon 5 of the murine
Dhcr7  gene, with similar biochemical and structural
defects and a 100 % neonatal lethality, has also been
reported [17]. Poor lung development or diffuse lung
alveolar atelectasis with cyanotic and lethargic breathing
are consistent between both Dhcr7 null models [16,17],
and therefore is the likely reason for the respiratory insuf-
ficiency and subsequent death of Dhcr7-/- pups. These
Dhcr7 knockout mice are models for human SLOS, espe-
cially the more severely affected patients, since early post-
natal lethality with respiratory failure has been reported in
severe SLOS cases [4,5]. Developmental lung abnormali-
ties are also relatively common in SLOS patients, includ-
ing pulmonary hypoplasia, abnormal pulmonary
lobation and pulmonary arteries, anomalies of laryngeal
and tracheal development [18].
Mammalian lung is unique in that it is fully developed,
but does not function for gas exchange until at the
moment of birth; the majority of structural development
and maturation takes place in utero. Lung development is
a complex process that involves branching morphogene-
sis of epithelium, interstitial development including vas-
culogenesis, cellular differentiation, biochemical
maturation and physical growth. Four stages of mouse
lung development have been described, based upon the
histological appearances of lung; pseudoglandular, canal-
icular, terminal saccular and alveolar stages [19].
Impaired hedgehog function has been proposed as a
mechanism underlying malformations found in SLOS.
Hedgehog family members play diverse roles in embry-
onic development, and cholesterol is necessary for matu-
ration of these morphogens [20-23]. The sonic hedgehog
(Shh) signaling cascade has been shown to play a central
role in lung development [24-26]. Loss of Shh function
resulted in severe lung defects associated with loss of
branching morphogenesis, but preserved proximal-to-dis-
tal differentiation of lung epithelium [24]. Overexpres-
sion of Shh in the distal lung epithelium resulted in the
absence of functional alveoli and an increase in interstitial
tissue caused by an increased proliferation of both epithe-
lial and mesenchyme cells [26]. Mice with Shh overex-
pression died less than 24 h after birth, probably owing to
respiratory failure. It has been reported that inhibition of
cholesterol biosynthesis by chemical inhibitors of Dhcr7
also led to a disturbance of the Shh signaling with abnor-
mal embryogenesis [27,28], and severe sterol deprivation
can indeed inhibit the processing of transfected Shh in
cultured mammalian cells [29].
In the present studies, we characterized lung development
in  Dhcr7-/-  embryos from E10.5 to birth. Our results
showed that cholesterol deficiency, caused by loss of
Dhcr7 activity, did not alter lung branching morphogene-
sis (early gestational stages, E9.5 to E14.5). However, lung
saccular development was impaired, with arrested or par-
tially developed epithelial tubules and delayed vascular
development. Differentiation of type II alveolar epithelial
cells (AECs) appeared normal but differentiation of type I
AECs was severely impaired. Therefore, cholesterol defi-
ciency resulted in a distinct late gestational lung hypopla-
sia, characterized by impaired sacculation with delayed
type I AECs differentiation and immature vascular devel-
opment. However, this study does not support the con-
cept that the perturbation of Shh-Patched-Gli pathway
was involved in the pathogenesis of developmental lung
hypoplasia in Dhcr7-/- embryos. Patterns of expression of
Shh signaling cascade members were not altered, and
processing of Shh appeared normal.
Results
Body growth retardation at late gestation stage in Dhcr7-
/- embryos
Dhcr7-/- mice were born in the expected Mendelian ratios
from heterozygous parents, but all of these pups died
within 24 h and most within 14 h of birth [16]. At birth,
they were clearly smaller than wild-type or heterozygousBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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littermates. An experienced investigator can pick out
knockout pups based on this along with presence of
hypoxia and their lack of spontaneous movement. The
breathing frequency in P0 Dhcr7-/- pups was markedly
slower than control littermates (34 ± 7 breaths/min in
Dhcr7-/-, n = 10 vs. 92 ± 16 breaths/min in controls, n =
32, p < 0.001) and the breathing was observed to be more
irregular and shallow, with long periods of apnea.
To determine the gestational stage at which growth of the
knockout embryos was affected, embryos were harvested
at various stages of gestation and their body lengths com-
pared between Dhcr7-/- and controls. A linear increase in
body length from E9.5 to E19.5 in control embryos was
observed (Fig. 1). No significant differences in body
length between wild-type and heterozygous embryos were
noted (data not shown). In contrast, knockout embryos
showed comparable body length growth until
E14.5~E16.5, then began to show a slower increase in
length, such that by E17.5, this was statistically significant
(18.87 ± 1.29 mm in controls, n = 15 compared to 16.69
± 1.05 mm in Dhcr7-/-, n = 7, p < 0.05, Fig. 1).
Dhcr7-/- embryos at late stages displayed pulmonary 
hypoplasia with delayed saccular development
Wet lung weights, as well as lung to body weight ratios
were significantly lower in Dhcr7-/- at E18.5 compared to
those in wild-type but not at E13.5 (Table 1). Both body
and lung weights were reduced, but lungs seemed to be
more affected. A representative figure of embryos at E10.5
and of the pups at birth was shown in Fig. 2A and 2B.
We examined the lungs for any gross morphological
abnormalities. The overall organogenesis of lungs was
preserved in Dhcr7-/- pups; four right lung lobes and a sin-
gle left lobe flanking the heart were easily seen on external
examination at birth (Fig. 2D). Examination for lobation
at E13.5 also showed comparable gross anatomy (Fig. 2C)
between wild-type and knockout embryos. Histological
analyses of the cardiopulmonary structures at E20.5,
taken just before birth to avoid artifacts from lack of lung
inflation, also confirmed normal gross anatomic develop-
ment (Fig. 2E and 2F). Additionally, no cardiac defects
were identified and this was confirmed by more detailed
histological analyses (data not shown). Thus, despite the
obvious hypoxia frequently observed at birth of the
Table 1: Whole body and lung weights of mouse embryos
E13.5 E18.5
Dhcr7+/+ Dhcr7-/- Dhcr7+/+ Dhcr7-/-
N 10 4 17 8
Wet BW (mg) 142 ± 0.21 138 ± 11 1015.3 ± 12 825.7 ± 14 *
Wet LW (mg) 8.1 ± 0.21 8.0 ± 0.4 43.44 ± 8.96 33.96 ± 11.37 *
LW/BW ratio (%) 5.7 ± 0.54 5.81 ± 0.55 4.4 ± 0.6 3.84 ± 0.63 *
* p < 0.05, compared to Dhcr7+/+. BW, body weight; LW, lung weight.
Body length growth curves Figure 1
Body length growth curves. Body length growth vs. gesta-
tional days is as shown. Control embryos (filled triangles, 
wild-type and heterozygous embryos were pooled together 
as there were no differences between these two groups) and 
knockout embryos (filled circles) were as shown. The growth 
curve showed a linear increase from E9.5 to E19.5 in con-
trols, but deviated at ~E14.5 in Dhcr7-/- embryos. Body 
lengths at E17.5 (18.87 ± 1.29 mm in controls, n = 15 vs. 
16.69 ± 1.05 mm in Dhcr7-/-, n = 7, p < 0.05), E18.5 (21.35 ± 
1.05 mm in controls, n = 15 vs. 19.38 ± 0.9 mm in Dhcr7-/-, n 
= 5, p < 0.05) and E19.5 (23.4 ± 0.97 mm in controls, n = 13 
vs. 20.3 ± 0.44 mm in Dhcr7-/-, n = 4, p < 0.05) were signifi-
cantly decreased, compared to those in controls. Results are 
expressed as mean ± s.d.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Embryonic size, lung morphology and histology at various stages of development Figure 2
Embryonic size, lung morphology and histology at various stages of development. Panel A shows the size and gen-
eral morphology of wild-type (+/+) and Dhcr7-/- (-/-) embryos at E10.5, without significant difference. At P0, the knockout pups 
were significantly smaller and appeared hypoxic (panel B). Panel C shows dorsal views of lungs from knockout and wild-type at 
E13.5 and panel D those at P0. Cross-sectional examination at the cardiopulmonary level at E 20.5 (prior to birth) showed nor-
mal lobar septation, but lungs from knockout animals were smaller in size and had less distal sac space (cf. panels E and F). 
Original magnification: Panels A and C, 2X; panels B and D, 0.7X; E and F, 2X. Labels: r, right; l, left; b, bronchial; br, bronchiole; 
e, esophagus; pa, pulmonary artery; ra, right atrium; la, left atrium; rv, right ventricle; lv, left ventricle.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
Page 5 of 18
(page number not for citation purposes)
knockout pups, major cardiac structural abnormalities
were not observed to account for this phenotype.
No distinguishable morphological differences were dis-
cernable between Dhcr7-/- and wild-type lungs at E10.5,
E13.5, E14.5 and E16.5 at low (10X) or high (40X) mag-
nifications (Fig. 3, panel A: a-h, data for E10.5 and E13.5
not shown). However, from E17.5 onwards, lungs from
knockout embryos appeared to have less saccular space
and relatively more mesenchyme compared to wild-type
lungs (Fig. 3, panel A: I-x). Lungs from control animals
showed normal progression with formation of sac-like
structures, the precursors of the alveoli (Fig. 3, panel A: i,
m, q and u). In lungs from knockout embryos, expansion
of epithelial tubules occurred but was significantly
delayed (Fig. 3, cf. panel A: j, n, r, v with i, m, q and u).
Morphometric measurements of lung sections at E17.5,
E18.5, E20.5 and in lungs from neonates showed that the
proportion of terminal sac space area was significantly
decreased in Dhcr7-/- lungs, compared wild-type lungs
(Fig. 3, panel B). Interstitial mesenchyme appeared
thicker and the lungs had less septation compared to con-
trol lungs. This 'thickening' of the alveoli may explain the
hypoxia frequently seen in Dhcr7-/- pups at birth.
Attenuated cell proliferation in late gestational Dhcr7-/- 
lungs
Does the loss of normal cholesterol biosynthesis lead to
abnormalities of cell proliferation/division or cell death?
Cell proliferation was examined by immunostaining for
PCNA and also by BrdU incorporation. Both PCNA and
BrdU staining of wild-type and knockout lungs at early
gestational stages (E13.5 and E14.5) showed comparable
patterns (Fig. 4, panels A-D). However, a clear reduction
of PCNA and BrdU labeling was visualized in distal lungs
of knockout embryos at late gestational stages (E18.5 and
E20.5, Fig. 4, panels E-H). Attenuated PCNA labeling was
also noted in knockout hearts at term (Fig. 4, cf. panels I
and J). When lungs were stained for pHH3, a marker of
active cell division, a clear reduction of pHH3 expression
in the epithelium of knockout lung was observed at E20.5
but not at E14.5 (Fig. 4, panels K, L, O and P). In contrast,
using the TUNEL assay, no apparent differences in cell
apoptosis rates were observed between wild-type and
knockout lungs at E18.5 (Fig. 4, cf. panels M and N). Thus,
at the late gestational stages, cell proliferation/division
was impaired in knockout embryos with no increase in
cell death rates.
Sterol content of developing lungs in Dhcr7 deficient mice
Markedly elevated 7-DHC/8-DHC levels and reduced
body cholesterol levels have been reported previously in
Dhcr7-/- P0 mice [16,17]. A significant amount of choles-
terol was detectable in lungs of Dhcr7-/- mice, comprising
~60% and ~30% of total tissue sterols at E13.5 and
neonate, respectively. In contrast to the doubling of cho-
lesterol in the lungs of wild type embryos (1.82 mg/g tis-
sue at E13.5 to 3.55 mg/g tissue at P0), cholesterol content
in the lungs of Dhcr7 null embryos remained at almost
constant low levels between E13.5 and P0 gestational
stages (Fig. 5). There was a progressive increase in 7-DHC
and 8-DHC; the latter is generated as a spontaneous
isomerization from the former. Total sterols at birth were
reduced in lungs of the Dhcr7 null mice, but were only
lower by ~30% (Fig. 5, see values for P0 mice).
Cholesterol is absolutely required for steroid hormone
synthesis by the adrenal glands. Adrenal insufficiency, as
has been reported in some severe cases of SLOS patients,
could be responsible for the lung hypoplasia and perina-
tal lethality [30]. Steroids, but particularly corticosteroids,
are necessary for lung maturation, especially the synthesis
and secretion of surfactant components [31]. We deter-
mined plasma corticosterone levels in P0 mice within 12
h of birth. Wild type P0 mice had corticosterone levels of
158 ± 50 ng/ml (n = 11), compared with 225 ± 50 ng/ml
(n = 7, p < 0.01) in Dhcr7-/- P0 mice. Thus, the corticoster-
one levels in Dhcr7-/-  mice were not decreased, but
increased by ~40%. However, since these P0 mice were
dying, perhaps this increase was sub-optimal given the
stress. Nevertheless, an absolute lack of corticosterone was
not present in these knockout pups.
To further rule out any effects of corticosterone deficiency
on lung immaturity, we examined lungs for surfactant
protein expression. Surfactant protein C, as determined by
IHC, was comparable in lung sections from wild-type or
Dhcr7 null embryos at either E18.5 or at E20.5 gestational
ages (Fig. 6, panel A). Northern analyses for SP-A, SP-B,
SP-C or SP-D showed no significantly differences between
wild-type and Dhcr7 null mice at term (Fig. 6, panel B).
Thus, surfactant protein expression was not altered by
Dhcr7 deficiency.
Dhcr7-/- lungs showed abnormal differentiation of type I 
alveolar epithelial cells (AECs)
At E20.5, the distal lung of wild type embryos consisted of
saccular structures lined by flat type I AECs, and by cuboi-
dal surfactant-producing type II AECs (Fig. 7A). In con-
trast, the formation of these typical saccules was impaired
in Dhcr7 deficient lungs. Instead, these saccular structures
were lined by a low columnar epithelium that lacked flat-
tened type I-like cells with the presence of many undevel-
oped or arrested epithelial tubules (Fig. 7B). Consistent
with disruption of type I AECs differentiation was the dra-
matic reduction of expression of T1α, an apical mem-
brane protein marker of lung type I AECs (Fig. 7, cf. panels
C and D). Decreased immunostaining for AQP5, another
type I AEC marker, was also noted in Dhcr7 deficient
lungs at E20.5, compared to control lungs (Fig. 7, cf.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Histological analyses of lungs at various embryonic stages Figure 3
Histological analyses of lungs at various embryonic stages. Panel A indicates lung sections stained with H and E, and 
taken at various gestational stages as indicated. The first two columns are at lower magnification (10X) and the last two col-
umns at higher magnification (40X). The first and third columns are representative sections from wild-type (+/+) embryos and 
the second and fourth columns from knockout (-/-) embryos. No differences were visible at E14.5 or E16.5 (panel A, a-h). Sig-
nificant differences were visible from E17.5 onwards (panel A, i-x). Distal tubules showed dilation and mesenchyme thinning, 
with progression of septation in wild-type lungs (panel A, i, m and q), whereas the knockout lungs showed less saccular struc-
tures and more mesenchyme (panel A, j, n and r). At higher magnifications of wild-type lungs (panel A, k, o and s), developing 
pre-alveoli and thinning mesenchyme (arrowheads) were seen but sections from knockout embryos showed a delay in this 
sequence of development (panel A, l, p and t). At birth, lungs from knockout pups showed deficient septation and thick-walled 
mesenchyme (panel A, x, arrowheads). Labels: de, distal epithelium; m, mesenchyme; PA, pulmonary artery; a, pre-alveoli; b, 
bronchi. Panel B shows the morphometric analyses of lung terminal sac spaces in lungs at various gestational stages. A signifi-
cant reduction in the terminal sac space was noted from E17.5 onwards. Results are expressed as mean ± s.d.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
Page 7 of 18
(page number not for citation purposes)
Analyses of cell proliferation, cell division and cell death Figure 4
Analyses of cell proliferation, cell division and cell death. Cell proliferation (PCNA: panels A, B, E and F; BrdU: panels 
C, D, G and H), cell division (pHH3: panels K, L, O and P) and cell death (TUNEL: panels M and N) were analyzed by immunos-
taining on lung sections at early and late gestational stages. Both PCNA and BrdU labeled cells in both epithelial and mesenchy-
mal regions were comparable at early stages (E14.5 for PCNA and E13.5 for BrdU) between wild-type (+/+) and knockout (-/-
) lungs. Positively stained cells in distal lungs at late stage (E20.5 for PCNA and E18.5 for BrdU) from knockout lungs were 
markedly reduced, compared with wild-type. PCNA labeling of cardiac muscle was also attenuated in knockout embryos at 
E20.5 (cf. panels I and J). No apparent differences in TUNEL immunostaining were observed in lung sections at E18.5 between 
wild-type and knockout. The pHH3 immunostaining was comparable between wild-type and knockout lungs at E14.5, and the 
lungs from wild-type at E20.5 showed a high index of positive cells, whereas lungs from knockout showed a apparent reduced 
staining pattern. Note the dividing cells are mainly epithelial. Original magnification: A-D and G-N are 20X; E, F, O and P are 
40X.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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panels E and F). Megalin, a low density lipoprotein recep-
tor (LDLR) gene family member, is expressed by embry-
onic epithelial cells and can function as an endocytic Shh
receptor [32]. Megalin was highly expressed on the distal
epithelium at E20.5 from wild-type lungs, as well as type
I AECs lining the developed saccules (Fig. 7G). In contrast,
though megalin staining was detected in developing sac-
cules in knockout embryonic lungs, its expression was
confined to undifferentiated cuboidal cells (Fig. 7H), fur-
ther indicating a delay in type I AECs differentiation in the
knockout lungs.
Delayed vascular development in Dhcr7-/- lungs
There is a close relationship between blood vessel devel-
opment and lung structural development. At later lung
developmental stages, timed capillary bed development is
essential for the formation of mature alveolar gas-
exchange, with a loss of mesenchyme separating the cap-
illary beds and the AECs [19]. In Dhcr7-/- lungs at late ges-
tational stages, the relative abundance of mesenchyme
was consistent with the general arrest in sacculation. To
investigate whether the delayed lung sacculation also
involved abnormal blood vessel development, immunos-
taining for the α-isoform of caveolin-1 (cav-1α) and plate-
let endothelial cell adhesion molecular (PECAM-1) were
performed on sections from wild-type and Dhcr7-/- lungs.
In the developing lung, cav-1α is expressed strictly in the
endothelium of developing capillary and blood vessels.
Cav-1α is present in the terminally differentiated type I
AECs, but is not detectable in its progenitors or type II
AECs [33]. At E14.5, both the epithelium and mesen-
chyme were negative for cav-1α staining, and cav-1α was
detected in the developing blood vessels and capillaries,
with no differences observed between wild-type and
Dhcr7-/-  lungs (Fig. 8, panels A and B). Cav-1α
immunostaining demonstrated that the vascular
development proceeded rapidly during saccular stages in
normal lungs (E17.5 and E20.5). In near-term normal
lungs (E20.5), an extensive vascular network, associated
with markedly thinned septation walls of well-developed
alveoli and close apposition to flat type I AECs, was
observed (Fig. 8, panels C and E). In contrast, the cav-1α
patterns in lungs from Dhcr7-/- embryos revealed a rela-
tively undeveloped pulmonary capillary bed (Fig. 8, pan-
els D and F). At E20.5, cav-1α stained cells in knockout
lungs were embedded in a relatively thick mesenchyme
surrounding undeveloped epithelial tubules, and these
epithelial cells remained cuboidal, instead of flattening
out (Fig. 8, panel F). PECAM-1 staining at E20.5 con-
firmed the delayed lung vascular development at these
late gestational stages in Dhcr7 deficient embryos (Fig. 8,
cf. panels G and H).
Is the pattern of sonic hedgehog expression or signaling 
altered in Dhcr7-/- embryos?
Shh is critical for normal embryonic development and its
autoprocessing, resulting in a cholesterol molecule cova-
lently attached at its C-terminus, is a necessary step for its
regulated signaling function [23,34]. Thus, disruption of
cholesterol biosynthesis could conceivably disrupt its
pattern of distribution and thus affect normal develop-
ment. To determine whether aberrant expression of Shh
contributed to the Dhcr7-/- lung phenotype, distribution of
Shh in the Dhcr7-/- and wild-type lungs was assessed from
E10.5 to P0 by IHC using Shh-N peptide antibody. At
E10.5, the distribution of Shh was detected in the epithe-
lial cells of lung buds (Fig. 9, left panel: C and D), as well
as in the more typical Shh-expressing locations, such as
the floor plate, notochord and mid gut (Fig. 9, left panel:
A-D). Importantly, no differences between Dhcr7-/- and
control embryos were noted. Likewise, examination of
lung sections from increasing gestational ages through to
birth showed no significant differences between wild-type
and Dhcr7 deficient tissues. The patterns of staining
observed were comparable to those previously reported
for Shh in mouse lungs [25].
To further investigate Shh signaling in these embryos, we
examined the patterns of expression of Patched (Ptch), a
cognate receptor for Shh and one whose expression is also
regulated by Shh signaling. The patterns of Ptch in lung
sections from various gestational stages were also
Sterol analyses of embryonic lungs Figure 5
Sterol analyses of embryonic lungs. Sterol contents, 
including cholesterol (black bars) and 7DHC/8DHC (white 
bars), were quantitated by GC-MS in the lungs from wild-
type (+/+) and knockout (-/-) embryos. Results are expressed 
as mean ± s.d and the number of lungs analyzed is as indi-
cated. Total sterols were lower at all stages in knockout 
lungs, with almost no increase in cholesterol content with 
time (black bars), but there was a progressive increment in 
the precursor sterols, 7DHC/8DHC (open bars), with 
increasing gestation.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Surfactant protein expression in lungs Figure 6
Surfactant protein expression in lungs. Panel A shows the immunostaining patterns for SP-C in lungs at E18.5 and E20.5 
from wild-type (+/+) and knockout (-/-) embryos. No significant differences in the patterns of SP-C staining were evident 
between wild-type and knockout lungs (panel A, a-d). Note that the underdeveloped epithelial tubules in knockout lungs also 
expressed SP-C (panel A, b and d, arrowheads), indicating normal type II AECs differentiation. Original magnification: 10X. 
Panel B, left-hand panel, shows a representative result from Northern analyses of total RNA from wild-type, heterozygous and 
knockout P0 lungs for SP-A, SP-B, SP-C and SP-D expression. Densitometry analyses showed the relative expression (n = 3, 
mean ± s.d.) of these surfactant protein mRNAs were not significantly different between these three genotypes.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Characterization of type I AECs differentiation Figure 7
Characterization of type I AECs differentiation. The normal distal saccules of wild-type (+/+) at near term (E20.5) 
showed typical type I (t1) and type II (t2) epithelial cells (panel A, arrowheads), but knockout (-/-) littermate lungs showed less 
developed saccules lined by columnar epithelial cells (panel B, black arrowheads), with partially arrested tubules in the distal 
lung (panel B, green arrowheads). Immunostaining for type I cell markers T1α and AQP5 demonstrated an intense staining in 
flat epithelial cells in wild-type lungs at E20.5 (panels C and E, arrowheads). In contrast, in knockout littermate lungs, T1α and 
AQP5 staining was dramatically decreased (panels D and F, arrowheads). Megalin expression (Meg) was detected in the airway 
epithelial cells, but not in proximal bronchiole epithelial cells (data not shown) in the lungs from both wild-type and knockout 
at E20.5. The elongated megalin-positive epithelial cells, lining the normally developed sacculi, were readily evident in many 
areas of the wild-type lungs. In contrast, the terminal epithelial cells positively stained by megalin antibodies in knockout lungs 
were comprised mainly of undifferentiated cuboidal cells (compare the arrowheads in G and H). Original magnification: A, B, G 
and H are 60X, C-F are 40X.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Immunostaining patterns for caveolin-1α and PECAM-1 in lung sections Figure 8
Immunostaining patterns for caveolin-1α and PECAM-1 in lung sections. Cav-1α staining was compared at E14.5, 
E17.5 and E20.5 stages of development. Both the epithelium and mesenchyme were negative for cav-1α at E14.5. Developing 
blood vessels (red arrowheads) and capillaries (arrows) (panels A and B) were stained positively for cav-1α, but the staining 
patterns between wild-type (+/+) and knockout (-/-) lungs were not altered. Cav-1α was also detected at the proximal bron-
chiole sub-epithelial matrices (panels A-D, black arrowheads). At E17.5, the airway epithelium, negative for cav-1α staining, was 
surrounded by rings of cav-1α positively stained capillary networks (panels C and D, arrows). Cav-1α expression patterns in 
lungs from knockout embryos at E17.5 were similar to wild-type embryos, but relative less capillary bed was noted in knockout 
lungs (cf. panels C and D). At E20.5 of wild-type lungs, both cav-1α and PECAM-1 staining demonstrated an extensive vascular 
network in the well developed saccules, with staining observed in close proximity to flat epithelial cells lining the air spaces 
(panels E and G, arrows). However, delayed vascular development was observed in knockout lungs, showing capillaries (panels 
F and H, arrows) of the knockout lungs at E20.5 were embedded in a relatively thick mesenchyme around the undeveloped epi-
thelial tubules in which the epithelial cells were remained cuboidal (arrowheads). Original magnification: A-D are 20X; E-H are 
40X.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Shh and Ptch expression patterns at different gestational stages in Dhcr7-/- and wild-type mice Figure 9
Shh and Ptch expression patterns at different gestational stages in Dhcr7-/- and wild-type mice. Left panel shows 
the Shh immunostaining patterns using an antibody to Shh N-peptide at various gestational stages as indicated by the legend on 
the y-axis. There were no significant differences noted at any of the stages examined between wild-type (+/+) and knockout (-
/-) embryos. At E10.5, Shh was detected in the floor plate (fp), notochord (nc) (A and B), mid-gut (mg) and the epithelial buds 
of lungs (lb) (C and D). Shh staining was restricted to epithelial cells in the distal region of the primordial tubes of lungs at E13.5 
and E15.5. Note that proximal epithelial cells of primordial tubes were not immunostained for Shh (E and F, arrows). Shh was 
detected in the lung epithelial cells on E18.5, and mainly in the conducting airways in the neonates. Original magnifications: 
A~H, K and L are 10X, I and J are 20X. Right panel shows the patterns of Ptch IHC at various gestational stages. Immunostain-
ing of Ptch from E13.5 to P 0 confirmed concordance with Shh expression and was not significantly different between wild-type 
and knockout embryos. Note that the proximal epithelial cells of primordial tubes were also not immunostained for Ptch at 
E13.5 lungs (arrows). Original magnifications: A~F, I and J are 10X. G and H are 20X.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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Comparisons of Smo, Gli1 and Gli3 expression in lung sections Figure 10
Comparisons of Smo, Gli1 and Gli3 expression in lung sections. Smoothened (Smo, upper panel), Gli1 (middle panel) 
and Gli3 (bottom panel) showed a pattern of distribution similar to that seen with Shh and Ptch (compare to Fig. 7). No differ-
ences between wild-type (+/+) and knockout (-/-) embryos were evident. Original magnifications: 20X.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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indistinguishable between wild-type and knockout
embryos (Fig. 9, right panels). The expression of Ptch was
in concordance with that of Shh (Fig 9, left and right pan-
els), showing lung epithelial cell expression. Downstream
of the Shh-Ptch signaling cascade are proteins such as
smoothened (Smo), and Gli proteins, key regulators of
target-gene expression in response to Shh signaling. No
differences in expression patterns for Smo (Fig. 10, upper
panels), Gli1 (Fig. 10, middle panels) or Gli3 (Fig. 10,
bottom panels) were noted between wild-type and knock-
out lungs at E13.5, E15.5 and E17.5 gestational days.
Shh protein processing in Dhcr7-/- embryos
Since Shh expression, as well as some of the Shh signaling
components appeared to be normal in Dhcr7-/- embryos,
endogenous autoprocessing of Shh to generate a choles-
terol-modified N-terminal fragment of Shh (Shh-Np) was
evaluated. COS-1 cells, transfected with full length Shh
cDNA (capable of endogenous autocleavage) or a trun-
cated Shh cDNA (Shh-N, expression of the shorter form
constitutively) were used as controls (Fig. 11, tracks 1 and
2). Transfection of the full-length cDNA for Shh led to the
detection of an ~20 kD protein that corresponds with the
cleaved and tailed Shh (Fig. 11, track 1), as previously
described [35]. Transfection of COS cells with the consti-
tutive truncated Shh-N cDNA led to two slower migrating
bands that correspond to truncated Shh, but which are
thought to be generated by differences in lipid modifica-
tions, as previously demonstrated [35]. In tissue lysates
from wild-type, Dhcr7+/- and Dhcr7-/- embryos at E11.5, a
band running at the same position as Shh-Np (auto-
cleaved and tailed) was detected in all of the lysates. There
were no distinguishable differences between Dhcr7-/- and
the wild-type samples, suggesting that Shh autoprocessing
occurred normally, despite an absolute deficiency of cho-
lesterol in knockout embryos. More importantly, no band
corresponding to a full-length Shh (~45 kD) was present
in the lung lysates from the knockout embryos, suggesting
that processing of Shh was not impaired.
Discussion
The elucidation that SLOS is caused by a defect in an
enzyme necessary for cholesterol biosynthesis has
improved our understanding of embryonic development.
This discovery has led to the identification of other
disorders of embryonic development caused by mutations
in genes encoding other enzymes in the post-squalene
steps of cholesterol biosynthesis. Although these genetic
studies now implicate the need for normal cholesterol
synthesis, the mechanistic role(s) of cholesterol in normal
embryonic development remains to be clarified.
In the present study, we report the characterization of lung
development in Dhcr7-/-  embryos. Although cardiac
abnormalities are common in human SLOS [36], no
structural abnormalities of the heart or the great vessels
were observed in the Dhcr7-/- pups. Lung development in
Dhcr7-/- embryos at the early stages, from lung bud forma-
tion to canalicular stage, was morphologically similar to
controls. Instead, a distinct lung hypoplasia at the saccular
stage, characterized by arrested or partially developed dis-
tal epithelial tubules, reduced terminal sac space, delayed
type I AECs differentiation and delayed vascular develop-
ment, was consistently observed at late gestational stages
in Dhcr7-/- embryos. At late stages of normal fetal develop-
ment, the mammalian alveolar epithelium undergoes an
abrupt differentiation as a part of the preparation of the
lungs for the postnatal demands of gas exchange [37].
Both type II AECs, producing pulmonary surfactants, and
type I AECs, lining the expanded alveoli, are important for
alveolar maturation. In addition, the vascular develop-
ment of alveoli is also essential for normal lung morpho-
genesis at late gestational stages [19]. We show here that
the differentiation of type I AECs but not type II AECs in
Dhcr7-/- lungs was blocked or delayed, as indicated by
Shh protein autoprocessing in mouse embryos Figure 11
Shh protein autoprocessing in mouse embryos. West-
ern blotting of lysates from wild-type (track 3), heterozygous 
(track 4) and knockout (track 5) embryos at E11.5, or COS1 
cells transfected with Shh (track 1) or Shh-N (track 2) were 
probed with anti-Shh-N19 antibodies. 20 µ g of lysate pro-
teins from Shh transfected COS1 cells and 75 µ g from 
embryos was loaded. Both unprocessed (Shh, upper arrow 
~45 kDa, faint signal) and processed (Shh-Np, lowest arrow, 
strong signal, track 1) forms of Shh were detected from Shh 
transfected COS1 cells. The two slower migrating bands in 
Shh-N transfected COS1 cells (track 2) represented Shh-N 
proteins with different lipid modifications at its N terminus. 
A major band running at the same position as processed Shh 
was detected in lysates from all the embryos (tracks 3–5). 
Importantly, no significant amounts of unprocessed or aber-
rantly migrating Shh proteins were detected in lysates from 
knockout embryos at this stage.BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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fewer flattened type I cells and by reduced expression of
markers of type I AECs, T1α and AQP5. Delayed vascular
development was also involved in the delayed sacculation
of Dhcr7-/- lungs. Additionally, the mesenchyme separat-
ing the AECs from the vascular beds remained thickened.
In support of normal differentiation of type II AECs, no
alteration in the gene expression patterns for surfactant
proteins A, B, C or D was noted, nor was the pattern of dis-
tribution of SP-C altered in lungs from knockout
embryos. Thus, impaired gas exchange, as opposed to
poor inflation and alveolar tension, may be the cause of
respiratory failure in these pups.
Loss of functional Dhcr7 led to a retardation of embryonic
growth from E14.5~E16.5 onwards. By this stage, choles-
terol levels were already lower and its immediate precur-
sor, 7-DHC, elevated in the lungs (this study) as well as in
the whole body [16,17]. Intrauterine growth retardation
(IUGR) followed by postnatal failure to thrive is a univer-
sally observed phenotype in SLOS patients [2,18]. We
showed here that body length was significantly reduced at
later stages of gestation in Dhcr7-/- animals, compared to
controls. Whole body weights and fresh lung weights (as
well as brain, heart and kidney, data not shown) at late
gestational stages were also lower in Dhcr7-/- embryos.
Interestingly, the lower lung/body ratios at E18.5 in
Dhcr7-/- embryos compared to wild-type suggested a dis-
proportionate inhibition of lung growth than other
organs. Cell proliferation and division in Dhcr7-/- lungs
were markedly arrested without apparent increase in cell
apoptosis. Therefore, it appears that growth retardation
caused by cholesterol deficiency was primarily because of
an inhibition of cell growth and proliferation, rather than
an increase in cell death.
Cholesterol is present in Dhcr7-/- embryos, as it is in Sc5d-
/-  (lathosterolosis) and Dhcr24-/-(desmosterolosis)
embryos [15,38]. Total sterols and cholesterol in Dhcr7-/-
embryonic lungs (as well as in brain and liver, data not
shown) were reduced and 7DHC/8DHC elevated, but a
significant amount of cholesterol was detectable,
comprising ~60% and ~30% of total tissue sterols at E13.5
and neonate, respectively. Fetal cholesterol can either be
synthesized endogenously in fetal tissues or accrued from
extra-embryonic tissues such as maternal serum, placenta,
and yolk sac [39]. Since these mice theoretically can not
synthesize cholesterol, any accumulation of cholesterol
must be derived from the maternal sources. Interestingly,
Dhcr24 null mice are viable but contained almost no cho-
lesterol in plasma and tissues at 3-months, whereas cho-
lesterol content in Dhcr24 null embryo tissues accounts
for ~60% at E11.5 and ~30% at E17.5, of total tissue ster-
ols [38]. These results, as well as this study, suggest that a
considerable amount of maternal cholesterol can be trans-
ferred to the murine fetus. One explanation of why the
Dhcr24-/- mice are developmentally normal but Dhcr7-/-
mice are affected may be because desmosterol can
functionally substitute for cholesterol, whereas the other
cholesterol precursors can not.
Although a mechanistic understanding of why a defi-
ciency in cholesterol biosynthesis leads to abnormal
embryonic development is lacking, a frequently advanced
explanation has been that Shh signaling, involved in early
developmental patterning, may be disrupted. In the devel-
oping lung primordium, Shh is expressed initially at E9
and promotes branching morphogenesis, which is
impaired in Shh knockout mice [24], suggesting that Shh,
secreted by the epithelium, is critical for branching
morphogenesis. In this study, the lack of evidence of
abnormal lung branching morphogenesis in the early
stages, but a consistent delayed maturation of the gas-
exchange region of the lung in the saccular period of
development of Dhcr7-/- embryos was observed, suggest-
ing early Shh signaling was normal. Shh protein expres-
sion and autoprocessing at E11.5 was indistinguishable
between wild-type and Dhcr7-/- embryos. Additionally,
although these experiments were not quantitative, the
abundance of Shh appeared unchanged between these
genotypes. Thus, it is possible that the cholesterol levels
(roughly 50% of normal levels) in Dhcr7-/- embryos were
enough for completion of Shh autoprocessing or 7DHC
accumulated in Dhcr7-/- embryonic tissues can also partic-
ipate efficiently as a sterol adduct in the Shh processing
reaction [20]. In this study, we also examined the Shh sig-
naling pathway by immunohistochemistry of known key
components of this pathway, such as patched,
smoothened and Gli proteins. Shh signaling leads to the
activation of transcription and increased protein levels of
these components [40-42]. If Shh signaling were defective
in Dhcr7-/- embryos, these could have resulted in abnor-
malities of the staining patterns of these components, but
no such disturbance was detected. Indeed, the patterns of
protein expression seemed comparable and indistinguish-
able from wild-type embryos at all stages of lung develop-
ment examined.
In a recent in vitro study [43], mouse embryonic fibrob-
lasts (MEFs) from Dhcr7-/-  embryos, grown in lipid-
depleted culture and transiently treated with cyclodextrin,
showed no affect on Shh processing. However, a defi-
ciency in their ability to respond to Shh activation, as
judged by reporter gene expression, was demonstrable. In
contrast, when CHO cells, that stably expressed Shh, were
subjected to sterol deprivation, an arrest of Shh
autoprocessing was clearly demonstrable [29]. In the
present study, we did not detect unprocessed Shh in
Dhcr7-/- embryonic tissues at E11.5. Subtle differences in
Shh signal transduction can not be excluded by the
present study. However, we favor a model whereby theBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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loss of normal cholesterol biosynthesis is important, not
so much for Shh autocleavage, as for the loss of the correct
plasma membrane milieu. Since the loss of cholesterol
content in the plasma membrane (and perhaps any mem-
brane) is likely to alter the function of receptors more sen-
sitive to this, loss of normal cholesterol synthesis may
cause a loss of signal transduction of a host of such path-
ways. Thus, this effect may not be limited to the Shh path-
way and other targets may be more important. This
hypothesis is amenable to testing in the Dhcr7 null mice.
Conclusion
Cholesterol deficiency caused by Dhcr7 deficiency in mice
resulted in, along with IUGR, a distinct lung saccular
hypoplasia with impaired differentiation of type I but not
type II AECs and delayed associated vascular develop-
ment. Loss of the correct amounts of cholesterol in the
membranes may perturb those receptors that depend
upon cholesterol for efficient signal transduction. Further
investigation of which transcriptional and signal trans-
duction pathways are more significantly affected by the
loss of Dhcr7 will be critical to elucidate the mechanism of
lung hypoplasia of this model, as well as the role of cho-
lesterol in embryonic development.
Methods
Animals
All mice were housed in an animal facility at 22°C with a
12 h light ~12 h dark cycle and all protocols were
approved by the Institutional Animal Welfare Committee.
Dhcr7 heterozygous animals used in this study have been
backcrossed onto a C57BL/6J background for 11 succes-
sive generations. The presence of vaginal plugs was con-
sidered as embryonic day (E) 0.5. Timed pregnant females
were sacrificed, embryos dissected from the uteri and
placed in 1X PBS. Crown-rump lengths of the embryos
were measured by use of an electronic digital caliper and
embryos weighed, after blotting off excess fluid. Each lung
was removed intact from the thoracic cavity, blotted free
of excess fluid, and weighed. Mice were classified as P0
when birth was witnessed and their breathing activities
visualized under a dissecting microscope. Digital images
of embryos or lungs were captured using a Zeiss-1000 dis-
secting microscope. Genotyping was performed by PCR,
as described previously [16]. And in selective cases, South-
ern blotting was performed for confirmation of Dhcr7
genotype.
Biochemical measurements
Tissue sterol compositions were analyzed by gas chroma-
tography-mass spectrometry (GC-MS) as described previ-
ously [2,44]. Serum corticosterone levels were measured
by radioimmunoassay (RIA) on the blood obtained from
decapitated neonates by a commercial source (DRTC hor-
mone Assay Core Lab, Vanderbilt University, TN).
Histology and Immunohistochemistry
Thoracic parts from embryos or P0 mice were fixed in
either Amsterdam's fixative (methanol:acetone:acetic
acid:water, 35:35:5:25 v/v) or 4% paraformaldehyde in
PBS. Tissues were fixed overnight at room temperature
(RT), rinsed in PBS, dehydrated in a graded ethanol series,
cleared in toluene and embedded in paraffin. Five µ m sec-
tions were mounted on Superfrost-Plus slides (VWR, West
Chester, PA) for histological or immunohistochemistry
(IHC) analyses.
IHC was performed using an indirect method. After
deparaffination in xylene and rehydration through a
graded series of ethanol, sections were heated at 95°C in
10 mM sodium citrate (pH 6.0) for an initial 15 min and
for three successive 5-min periods [25]. After cooling, the
sections were treated with hydrogen peroxide (3% v/v in
PBS, pH7.4) for 10 min and rinsed in the PBS. Sections
were blocked with 5% normal serum for 2 h, washed in
PBS and incubated with antibodies against Shh-N19
(1:100), Patched (1:100), Smo-N19 (1:100), Gli1
(1:100), Gli3-N19 (1:100), SP-C C19 (1:200), caveolin
1α-N20 (1:200), aquaporin 5 (AQP5, 1:200), megalin
(1:200), PECAM-1 (1:200) (Santa Cruz Biotechnology,
Santa Cruz, CA) or T1α (mAB 8.1.1, 1:1000 dilution,
Developmental Studies Hybridoma Bank, Iowa City, IA)
overnight at 4° C in a humidified chamber. The sections
were washed in PBS, incubated with biotinylated
secondary antibodies (1:1000~1:5000, Santa Cruz Bio-
technology) in PBS for 2 h at RT, incubated with HRP-
streptavidin complex for 30 min, rinsed in PBS and visu-
alized using a Metal Enhanced Diaminobenzidine (DAB)
Substrate Kit (Pierce, Rockford, IL). Digital images were
collected using a Polaroid Digital Microscope Camera
mounted on an Olympus BX40 microscope.
Lung morphometry
Terminal saccular space areas were measured using NIH
Image software (NIH, Bethesda, MD) as previously
described [45]. Multiple measurements were performed
on randomly selected 0.04-mm2 fields located in the dis-
tal part of the lung sections. The proportion of lung com-
prising terminal saccular spaces was calculated as a
percentage of the total examined area of the lung section.
Three animals per genotype were examined.
Assessment of cell proliferation/Division/death
Changes in cell proliferation and division were assessed
by proliferating cell nuclear antigen (PCNA) IHC, bromo-
deoxyuridine (BrdU) incorporation and phosphorylated
histone H3 (pHH3) IHC. The PCNA (1:2000) and pHH3-
Ser28 (1:200) antibodies were obtained from Santa Cruz
Biotechnology. For BrdU incorporation, timed pregnant
mice at E18.5 were injected intra-peritoneally with 100
µg/gm body weight of BrdU (Sigma, St Louis, MO) 2 hBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/1
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prior to sacrifice, embryos dissected from uteri and proc-
essed as described above. Sections were stained with a
monoclonal anti-BrdU antibody (1:100, Developmental
Studies Hybridoma Bank, Iowa City, IA) and visualized
with a Cy2-conjugated rabbit anti-mouse antibody using
a laser-scanning confocal microscope. Cell death was
investigated by terminal deoxynucleotidyltransferase-
mediated dUTP nick-end labeling (TUNEL) using the Flu-
orescein In Situ Cell Death Detection Kit (Roche, Indian-
apolis, IN) according to the manufacturer's protocol.
Western blotting
Sample preparation and western blotting was performed
according to Kawakami et al with some minor modifica-
tions [35]. Briefly, 3 embryos from each genotype were
pooled, homogenized in ice cold lysis buffer (50 mM Tris-
pH8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.5
mM DTT, 1 mM PMSF and 2 µg/ml each of aprotinin, leu-
peptin and pepstatin A) with a tissue homogenizer (PRO
Scientific Inc., Oxford, CT) using three pulses of 10 sec-
onds each and then subjected to Dounce homogenizer by
10 strokes. The homogenates were centrifuged at 10,000 g
for 30 minutes at 4°C, supernatants collected, protein
concentration determined and used for western blotting.
COS1 cells were transfected using Superfect transfection
reagent (Qiagen, Valencia, CA) with expression constructs
encoding either the full-length Shh or the N-terminal frag-
ment of Shh without post-translational modifications
(constructs kindly provided by Dr. Pao-Tien Chuang, Car-
diovascular Research Institute, University of California,
San Francisco, CA), harvested 3 days after transfection and
protein extracts prepared as described above. Protein con-
centration was determined using Bio-Rad protein assay kit
(BioRad, Hercules, CA) and 20 µg (COS1 cells) and 75 µg
(embryos) of lysates separated by 15 % SDS-PAGE, trans-
ferred onto nitrocellulose membrane, incubated with pri-
mary antibody (Shh-N19, 1:100) for 2 hours, followed by
donkey anti-goat HRP second antibody (1:1000) and vis-
ualized by chemiluminescent detection according to man-
ufacturer's protocols (Perkin-Elmer Life Sciences, Boston
MA).
Northern blotting
Northern blotting was performed as previously described
[46], using total RNA (20 µg) from P0 mice lungs. The
cDNA probes for SP-A, SP-B and SP-C were kindly
provided by Dr. Jeffery Whitsett (Division of Pulmonary
Biology, Cincinnati Children's Hospital Medical Center,
Cincinnati, Ohio). A cDNA probe for SP-D was amplified
by RT-PCR, using murine SP-D cDNA specific primers
(sense 5'-TGCCTGGTCGTGATGGACG-3', and antisense
5'-AGCACTGTCTGGAAGCCCGC-3') and confirmed by
sequencing.
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